March 7, 2020

Lars Wahlberg, M.D., PhD

Scientific Advisor, Senior Life Science Entrepreneur, Neurosurgeon, and Translational Scientist

Biotechnology entrepreneur, neurosurgeon, and translational scientist with 20 years of biotechnology R&D experience in developing biologics-based therapies for neurological disorders. Founder and CEO of Gloriana Therapeutics with successful track record in raising capital, grant funding, and partnership to move products from R&D into therapeutic product opportunities.

Familiar with EU and US regulatory environment, clinical trial application submissions, and early clinical trial execution. Multidisciplinary skills encompassing neuroscience, neurodegenerative disorders, stem cells, protein therapeutics, cell and gene therapy, and medical devices. Has established new and innovative therapeutic platforms and product concepts and associated intellectual properties and publications.